Our results suggest that Tau alterations lead to a loss of its nucleic acid safeguarding functions and participate in the accumulation of DNA and RNA oxidative damage observed in the Alzheimer’s disease (AD) brain. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.